Labrador Sciences

Labrador Sciences Inc.Labrador Sciences Inc. specializes in healthcare technology, particularly targeting home diagnostics. Founded in 2021 in Tel Aviv, Israel, the company has completed 2 deals.00 mn.The company specializes in delivering technological solutions, focusing primarily on advanced data analytics and cloud-based software applications. Their flagship offerings revolve around providing businesses with tools to streamline operations, enhance decision-making, and improve overall efficiency. These products are engineered to address specific pain points within various industries, including supply chain management, customer relationship management, and financial forecasting. The primary clientele includes mid to large-sized enterprises across sectors such as retail, logistics, and healthcare, with significant market penetration in North America and Europe.The company's revenue model is built around a subscription-based framework, allowing clients to access its suite of products for a recurring fee. This structure facilitates steady cash flow and enables customers to scale their usage based on demands. Partnerships with retail channels and direct-to-consumer sales further diversify revenue streams, highlighting a robust market presence. Flagship products are offered at various pricing tiers, which cater to different business sizes and requirements, ensuring accessibility for a wide range of customers.Labrador Sciences Inc.io Ltd, set to close on April 28, 2025.io's existing products, advancing at-home kidney diagnostics. The company will focus on developing new products that enhance at-home testing capabilities. Additionally, Labrador plans to expand its market presence beyond North America and Europe to target emerging markets in Asia and South America by the end of 2026.

1. Seed

   Jun 11, 2021

   Amount

   $5M

   Investors

   Locked